𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Using the LUCID method to optimize the acceptability of shared interfaces

✍ Scribed by Andy Smith; Lynne Dunckley

Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
855 KB
Volume
9
Category
Article
ISSN
0953-5438

No coin nor oath required. For personal study only.

✦ Synopsis

The Logical User Centred Interface Design (LUCID) method has been shown to provide a development approach which is both user-centred and which, with respect to selected usability criteria, leads to the identification of the optimum interface. Previously published evidence has focused on factors internal to the design of the interface itself. In this paper, the authors show how Taguchi techniques for total quality management, which are integrated within the method, can be extended to analyse external factors such as diversity within the user groups of shared interfaces. Application of the method to global, international and local interfaces is discussed.

πŸ“œ SIMILAR VOLUMES

A method to optimize the bandwidth of UW
A method to optimize the bandwidth of UWB planar monopole antennas
✍ D. Valderas; I. Cendoya; R. Berenguer; I. Sancho πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 392 KB

illumination on S 21 near pinch-off voltage. As the input optical power is increased, the forward gain is also increased. However, the phase of S 21 is insensitive to illumination, as is evident from Figure 4. Further, we plotted the variation in the remaining parameters (S 12 , S 22 ) with illumina

A theoretical method to improve and opti
A theoretical method to improve and optimize the design of bioartificial livers
✍ Adam J. Davidson; Marianne J. Ellis; Julian B. Chaudhuri πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 383 KB πŸ‘ 2 views

## Abstract Bioartificial livers (BALs) are a potentially effective countermeasure against liver failure, particularly in cases of acute or fulminant liver failure. It is hoped these devices can sustain a patient's liver function until recovery or transplant. However, no large‐scale clinical trial